XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Tables)
9 Months Ended
Jul. 01, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Company’s matching contributions to the Plan
The following table reflects the Company’s contributions to the Plans during the three and nine months ended July 1, 2017 and July 2, 2016:
 
Three months ended
 
Nine months ended
(in thousands)
July 1, 2017
 
July 2, 2016
 
July 1, 2017
 
July 2, 2016
Cash
$
390

 
$
376

 
$
1,307

 
$
1,194

Accumulated other comprehensive income reflected on the Consolidated Balance Sheets
The following table reflects accumulated other comprehensive (loss) / income reflected on the Consolidated Condensed Balance Sheets as of July 1, 2017 and October 1, 2016
 
As of
(in thousands)
July 1, 2017
 
October 1, 2016
(Loss) / Gain from foreign currency translation adjustments
$
(313
)
 
$
462

Unrecognized actuarial loss Switzerland pension plan, net of tax
(2,764
)
 
(2,726
)
Unrealized gain / (loss) on hedging
877

 
(462
)
Accumulated other comprehensive loss
$
(2,200
)
 
$
(2,726
)
Restricted stock and common stock granted
The following table reflects restricted stock and common stock granted during the three and nine months ended July 1, 2017 and July 2, 2016:
 
Three months ended
 
Nine months ended
(shares in thousands)
July 1, 2017
 
July 2, 2016
 
July 1, 2017
 
July 2, 2016
Market-based restricted stock
5

 
6

 
386

 
172

Time-based restricted stock
4

 
16

 
708

 
597

Common stock
10

 
15

 
35

 
47

Equity-based compensation in shares
19

 
37

 
1,129

 
816

Equity-based compensation expense
The following table reflects total equity-based compensation expense, which includes restricted stock, stock options and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended July 1, 2017 and July 2, 2016
 
Three months ended
 
Nine months ended
(in thousands)
July 1, 2017
 
July 2, 2016
 
July 1, 2017
 
July 2, 2016
Cost of sales
$
97

 
$
98

 
$
344

 
$
323

Selling, general and administrative (1)
2,179

 
1,331

 
7,363

 
2,021

Research and development
514

 
472

 
1,763

 
1,592

Total equity-based compensation expense
$
2,790

 
$
1,901

 
$
9,470

 
$
3,936

(1) The selling, general and administrative expense for the nine months ended July 2, 2016, includes the reversal of a $2.0 million expense due to the forfeiture of stock awards in connection with the October 2015 retirement of the Company's CEO.
The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended July 1, 2017 and July 2, 2016:  
 
Three months ended
 
Nine months ended
(in thousands)
July 1, 2017
 
July 2, 2016
 
July 1, 2017
 
July 2, 2016
Market-based restricted stock 
$
838

 
$
475

 
$
2,626

 
$
(518
)
Time-based restricted stock
1,756

 
1,246

 
6,289

 
3,958

Performance-based restricted stock 

 

 

 
(43
)
Common stock
196

 
180

 
555

 
539

Total equity-based compensation expense (1)
$
2,790

 
$
1,901

 
$
9,470

 
$
3,936

(1) The equity-based compensation expense for the nine months ended July 2, 2016, includes the reversal of a $2.0 million expense due to the forfeiture of stock awards in connection with the October 2015 retirement of the Company's CEO.